Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 1, 2008, Pages 125-131

  Devouassoux, G ^a,b,d   Pachot, A ^c   Laforest, L ^b   Diasparra, J ^c   Freymond, N ^a   Van Ganse, E ^b   Mougin, B ^c   Pacheco, Y ^a,b  

^a HCL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Aspirin induced asthma; Aspirin tolerant asthma; Galectin 10; mRNA microarray; Nasal polyposis

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; GALECTIN; GALECTIN 10; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE OVEREXPRESSION; GENETIC CORRELATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIROMETRY; VALIDATION STUDY;

ADULT; ASPIRIN; ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; GALECTINS; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 36649015384     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01558.x     Document Type: Article

References (41)

1. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2005 116 : 970 975.
2. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000 15 : 863 869.
3. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003 111 : 913 921.
4. Penrose JF, Baldasaro MH. Leukotriene C4 synthase: a candidate gene for the aspirin-intolerant asthmatic phenotype. Allergy Asthma Proc 1999 20 : 353 360.
5. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990 323 : 645 655.
6. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002 347 : 1493 1499.
7. Picado C. Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes. Allergy 2002 57 : 58 60.
8. Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000 16 : 44 49.
9. Mewes T, Riechelmann H, Klimek L. Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy 1996 51 : 506 510.
10. Pierzchalska M, Mastalerz L, Sanak M, Zazula M, Szczeklik A. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy 2000 30 : 1785 1791.
11. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000 16 : 432 436.
12. Lee SH, Rhim T, Choi YS, Min JW, Kim SH, Cho SY et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006 173 : 370 378.
13. Min JW, Jang AS, Park SM, Lee SH, Lee JH, Park SW et al. Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest 2005 128 : 3127 3132.
14. Leonidas DD, Elbert BL, Zhou Z, Leffler H, Ackerman SJ, Acharya KR. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure 1995 3 : 1379 1393.
15. Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A et al. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 1993 150 : 456 468.
16. Abedin MJ, Kashio Y, Seki M, Nakamura K, Hirashima M. Potential roles of galectins in myeloid differentiation into three different lineages. J Leukoc Biol 2003 73 : 650 656.
17. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987 136 : 225 244.
18. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J 2000 16 : 615 620.
19. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004 20 : 307 315.
20. Pachot A, Blond JL, Mougin B, Miossec P. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 2004 114 : 121 124.
21. Pachot A, Monneret G, Voirin N, Leissner P, Venet F, Payen D et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol 2004 114 : 61 69.
22. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996 51 : 16 23.
23. Kowalski ML, Pawliczak R, Wozniak J, Siuda K, Poniatowska M, Iwaszkiewicz J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000 161 : 391 398.
24. Henderson WR Jr., Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002 165 : 108 116.
25. Altman LC, Munk Z, Seltzer J, Noonan N, Shingo S, Zhang J et al. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J Allergy Clin Immunol 1998 102 : 50 56.
26. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998 101 : 834 846.
27. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995 181 : 2119 2127.
28. Takafuji S, Tadokoro K, Ito K, Dahinden CA. Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol 1994 104 (Suppl. 1 27 29.
29. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002 48 : 1883 1890.
30. Debey S, Diening U, Schultze JL. An analysis of blood processing methods to prepare samples for GeneChip expression profilling. Affymetrix product family. http://www.affymetrix.com, 2003.
31. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002 29 : 23 39.
32. Kuwabara I, Liu FT. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996 156 : 3939 3944.
33. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000 165 : 2156 2164.
34. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000 156 : 899 909.
35. Yamaoka A, Kuwabara I, Frigeri LG, Liu FT. A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol 1995 154 : 3479 3487.
36. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 2004 165 : 2045 2053.
37. Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN. Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J Biol Chem 2002 277 : 14916 14924.
38. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998 273 : 16976 16984.
39. Dor PJ, Ackerman SJ, Gleich GJ. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. Am Rev Respir Dis 1984 130 : 1072 1077.
40. Sparrow CP, Leffler H, Barondes SH. Multiple soluble beta-galactoside- binding lectins from human lung. J Biol Chem 1987 262 : 7383 7390.
41. Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ et al. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002 277 : 14859 14868.